| Website | exagen.com |
| Category | BioTech |
| Phone | 505-272-7966 |
| Employees |
| TOTAL | $7M |
| VENTURE FUNDING TOTAL | $7M |
| Series B, 6/05 Tullis-Dickerson vSpring Capital Epic Ventures | $7M |
Exagen Diagnostics is a patient focused, discovery driven CLIA registered molecular diagnostics laboratory with a growing menu of proprietary, internally developed genomic tests. Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.
